Form 4 for LENZ LENZ Therapeutics, Inc.
Accepted 2025-11-07 00:00:00 ET · period of report 2025-11-07 · accession 0001815776-25-000072 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-07 | 2025-11-07 | LENZ | Chevallard Daniel R. | CFO | P - Purchase | $22.76 | +2,198 | 3,208 | +218% | +$50.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-07 | P | A | 2,178 | $22.76 | 5,386 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-07 | P | A | 20 | $22.71 | 3,208 | D | — | — |